Abiraterone Tosylate Impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Abiraterone Tosylate Impurity

● Under Development

Catalogue No.:VL830050
CAS No.:N/A
Mol. Formula:C31H37NO3S
Mol. Weight:503.7 g/mol

Additional information on Abiraterone Tosylate Impurity

Parent drug

Abiraterone

IUPAC Name

(3S, 8R, 9S, 10R, 13S, 14S)-10, 13-Dimethyl-17-(pyridin-3-yl)-2, 3, 4, 7, 8, 9, 10, 11, 12, 13, 14, 15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 4-methylbenzenesulfonate

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=S(C1=CC=C(C)C=C1)(O[C@H]2CC[C@]3(C)[C@@]4([H])CC[C@]5(C)C(C6=CC=CN=C6)=CC[C@@]5([H])[C@]4([H])CC=C3C2)=O

InChI

InChI=1S/C31H37NO3S/c1-21-6-9-25(10-7-21)36(33,34)35-24-14-16-30(2)23(19-24)8-11-26-28-13-12-27(22-5-4-18-32-20-22)31(28,3)17-15-29(26)30/h4-10,12,18,20,24,26,28-29H,11,13-17,19H2,1-3H3/t24-,26-,28-,29-,30-,31+/m0/s1

Description

The compound Abiraterone Tosylate Impurity is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Abiraterone. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. Abiraterone Tosylate Impurity is an intermediate formed during the synthesis of abiraterone is an Inhibitor of preandrogen enzyme that blocks androgen synthesis and is suitable for pharmacological treatment of disorders of preandrogen that is extremely active in both testes and adrenals.

References

Kiss, Anita, et al. “Synthesis of Novel 17-Triazolyl-Androst-5-En-3-Ol Epimers via Cu(I)-Catalyzed Azide-Alkyne Cycloaddition and Their Inhibitory Effect on 17a-Hydroxylase/c 17, 20 -Lyase.” Steroids, vol. 135, July 2018, pp. 79–91, https://doi.org/10.1016/j.steroids.2018.03.006. ?

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url